Feature | Artificial Intelligence | April 19, 2019 | By Greg Freiherr

Development of Artificial Intelligence in Women’s Health Emphasizes Value

Smart algorithms in Tomo, 2-D and ultrasound exemplify current efforts

In a demonstration on the exhibit floor of the SBI symposium, Koios software identified suspicious lesions in ultrasound images

In a demonstration on the exhibit floor of the SBI symposium, Koios software identified suspicious lesions in ultrasound images. Photo by Greg Freiherr

Commercial efforts to develop artificial intelligence (AI) for women’s health have tended toward smart algorithms that accelerate medical practices as they currently exist. At the Society for Breast Imaging (SBI)/American College of Radiology (ACR) Breast Imaging Symposium in early April, several companies, including iCAD, Lunit and Koios, showcased algorithms that embody this approach.

Profound AI from iCAD exemplifies how the current development of artificial intelligence can affect breast imaging. This software, which was cleared by the FDA in late 2018, helps physicians interpret digital breast tomosynthesis images. Its use aligns well with the goals of value-based medicine, which emphasizes increased efficiency, effectiveness and patient benefit.

In research that the company used to support its submission to the FDA, radiologists using Profound AI increased cancer detection rates, reduced false positive rates and reduced patient recalls. Using the software concurrently with physician interpretation also significantly decreased the time needed to interpret images, according to the research.

The software is designed specifically for 3-D tomo and, as such, does not address the prior and current 2-D mammograms that physicians often rely on to identify changes from previous screenings. ProFound AI for 2-D could be available, however, in the second quarter 2019, according to the company.

Typically the most current and prior screening mammograms are overlaid, when determining temporal changes. No algorithms are yet commercially available to help physicians spot these changes. Nor is there an AI algorithm that factors in patient risk characteristics, said Michael Klein, iCAD executive chairman and CEO. “So there is a long way to go,” said Klein, who noted, however, that at least one near-term solution from iCAD is on the way.

 

Other Vendors Exhibit Similar Software

Vendors at the SBI symposium exhibited similar kinds of AI-based software. These included an algorithm being developed by Lunit to analyze 2-D mammograms and one by Koios that does the same for sonograms.

Seoul-based Lunit, whose name is an abbreviation of “learning unit,” is developing AI for applications in mammography, both 2-D and tomo, as well as in CT of the chest and coronaries. The 2-D mammography software, now in review for FDA clearance and the CE mark from the European Union, detects breast cancer lesions with up to 97% accuracy in full field digital mammograms (FFDMs), according to the company. Lunit CEO Brandon B. Suh, M.D., described the software, called Lunit INSIGHT for Mammography, as a diagnostic support tool focused primarily on screening mammography.

“According to our clinical studies, the use of our product has been shown to significantly increase the cancer detection rate and (improve) the recall rate of radiologists,” Suh told ITN on the exhibit floor of the SBI symposium.

The Koios software aims to provide decision support for physicians and technologists using breast ultrasound. The company frames its software as a “diagnostic assistant.” There are two versions, according to Koios CEO and president Chad McClennan. One is compatible with major PACS, has cleared the FDA and is available commercially. The other is being tailored for use onboard GE Healthcare’s Logiq E10 high-performance ultrasound scanner.

“Ultrasound is ubiquitously available worldwide,” said McClennan, stating that this modality “is the standard of care for women with dense breasts tissue.”

The Koios algorithm examines ultrasound images then analyzes features and characteristics of suspicious lesions, delivering a probability of malignancy aligned with BI-RADS (Breast Imaging Reporting And Data System).

 

Greg Freiherr is a contributing editor to Imaging Technology News (ITN). Over the past three decades, Freiherr has served as business and technology editor for publications in medical imaging, as well as consulted for vendors, professional organizations, academia, and financial institutions.

 

Related Content:

VIDEO: How iCad Uses AI to Speed Breast Tomosynthesis

FDA Clears iCAD's ProFound AI for Digital Breast Tomosynthesis

Lunit Unveiling AI-Based Mammography Solution at RSNA 2018

Technology to Watch in Breast Imaging

 

 

Related Content

The Revolution Apex intelligent computed tomography (CT) scanner

The Revolution Apex intelligent computed tomography (CT) scanner. Image courtesy of GE Healthcare.

News | RSNA | October 18, 2019
At the 2019 annual meeting of the Radiological Society of North America (RSNA 2019), Dec. 1-6 in Chicago, GE Healthcare...
Selecting an AI Marketplace for Radiology: Key Considerations for Healthcare Providers
Feature | Artificial Intelligence | October 18, 2019
October 18, 2019 — As the nascent market for...
Surgical Institute of Reading Chooses RamSoft's PowerServer Lite PACS
News | PACS | October 18, 2019
Surgical Institute of Reading recently selected RamSoft’s PowerServer Lite PACS (picture archiving and communication...
While electronic medical record systems have helped consolidate most patient data into one location, medical imaging IT systems has proved to be more difficult to replicate by large EMR vendors. This has made room in the market for third-party radiology IT vendors that allow easy integration with the larger EMRs like Epic and Cerner. This image shows Agfa's enterprise imaging system, leveraging its ability to be accessed anywhere with internet connection and pull images from radiology and surgery.

While electronic medical record systems have helped consolidate most patient data into one location, medical imaging IT systems has proved to be more difficult to replicate by large EMR vendors. This has made room in the market for third-party radiology information system vendors that allow easy integration with the larger EMRs like Epic and Cerner. This image shows Agfa's enterprise imaging system, leveraging its ability to be accessed anywhere with an internet connection and able to pull in images from both radiology and surgery. 

Feature | Enterprise Imaging | October 17, 2019 | Steve Holloway
October 17, 2019 — The growing influence and uptake of electronic medical records (EMRs) in healthcare has driven deb
USF Health Expands Digisonics System With Vascular Reporting
News | Cardiac PACS | October 17, 2019
University of South Florida (USF) Health in Tampa, Fla., has enhanced their use of the Digisonics Cardiovascular...
Intelerad's nuage Patient Portal

Intelerad's nuage Patient Portal. Image courtesy of Intelerad.

News | Enterprise Imaging | October 17, 2019
Intelerad Medical Systems announced that OneWelbeck, a London operator of specialist facilities for minimally-invasive...
A patient prepares to have a tomosynthesis-guided prone breast biopsy using the Hologic Affirm prone biopsy system.

A patient prepares to have a tomosynthesis-guided prone breast biopsy using the Hologic Affirm prone biopsy system.

Feature | Breast Biopsy Systems | October 17, 2019 | By Harriet Borofsky, M.D.
The current body of research supporting...
An illustration of radiology department analytics data showing GE Healthcare’s business analytics software.

An illustration of radiology department analytics data showing GE Healthcare’s business analytics software.

Feature | Radiology Business | October 17, 2019 | By April Wilson
According to IBM, the world creates 2.5 quintillion bytes of data daily.
Feature | Artificial Intelligence | October 16, 2019 | By Siddharth (Sid) Shah
The period between November through February is pretty interesting for the field of medical imaging — two major confe
Feature | Breast Imaging | October 16, 2019 | By Jeff Zagoudis
On Jan. 1, 2017, the U.S.